BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9375836)

  • 1. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers.
    Flordal PA; Svensson J; Ljungström KG
    Thromb Res; 1991 Jun; 62(5):355-64. PubMed ID: 1716790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hemodialysis and long-term erythropoietin treatment on protein C, and on free and total protein S.
    Clyne N; Egberg N; Lins LE
    Thromb Res; 1995 Oct; 80(2):161-8. PubMed ID: 8588193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
    El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
    Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics.
    Aunsholt NA; Schmidt EB; Stoffersen E
    Nephron; 1989; 53(1):6-8. PubMed ID: 2506477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement.
    Flordal PA; Ljungström KG; Svensson J; Ekman B; Neander G
    Thromb Haemost; 1991 Dec; 66(6):652-6. PubMed ID: 1796409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C, protein S, and antithrombin III in twice-frozen plasma.
    Sivakumaran M; Long S; Drury M
    Transfusion; 2005 Feb; 45(2):281. PubMed ID: 15660840
    [No Abstract]   [Full Text] [Related]  

  • 11. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 12. A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
    Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
    Thromb Haemost; 1992 Nov; 68(5):625. PubMed ID: 1455414
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?
    Hsin Shieh H; Roseli Barreira E; Freitas Góes P; Bousso A; Ventura Brazilian GA; Melo AM; Ibidi SM
    Pediatr Crit Care Med; 2010 Nov; 11(6):767-8; author reply 768-9. PubMed ID: 21057275
    [No Abstract]   [Full Text] [Related]  

  • 14. Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation.
    Tabbara IA; Ghazal CD; Ghazal HH
    J Hematother; 1996 Feb; 5(1):79-84. PubMed ID: 8646485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III, protein C and protein S in children with chronic viral hepatitis B or C].
    Adamska I; Szaflarska-Szczepanik A; Chrobot A; Kulwas A; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2003; 7(2):289-97. PubMed ID: 12878800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between anti-coagulation system changes of coronary heart disease patients and different syndrome-type in TCM].
    Liang TJ; Gao SZ; Zhang FL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):599-600. PubMed ID: 8704425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP in uremia.
    Vicente V; Alberca I; Macias JF; Lopez Borrasca A
    Nephron; 1984; 36(2):145-6. PubMed ID: 6420716
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
    Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
    Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.